Aurelio Silvestroni
Aurelio Silvestroni
Research Scientist Engineer 3, University of Washington
Потвърден имейл адрес: uw.edu
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
M Björkqvist, EJ Wild, J Thiele, A Silvestroni, R Andre, N Lahiri, ...
The Journal of experimental medicine 205 (8), 1869-1877, 2008
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
A Silvestroni, RLM Faull, AD Strand, T Möller
Neuroreport 20 (12), 1098-1103, 2009
Dysregulated mi RNA biogenesis downstream of cellular stress and ALS‐causing mutations: a new mechanism for ALS
A Emde, C Eitan, LL Liou, RT Libby, N Rivkin, I Magen, I Reichenstein, ...
The EMBO journal 34 (21), 2633-2651, 2015
Regulation of cytotoxin expression by converging eukaryotic‐type and two‐component signalling mechanisms in Streptococcus agalactiae
L Rajagopal, A Vo, A Silvestroni, CE Rubens
Molecular microbiology 62 (4), 941-957, 2006
Characterization of the melA Locus for α-Galactosidase in Lactobacillus plantarum
A Silvestroni, C Connes, F Sesma, GS De Giori, JC Piard
Applied and Environmental Microbiology 68 (11), 5464-5471, 2002
Regulation of purine biosynthesis by a eukaryotic‐type kinase in Streptococcus agalactiae
L Rajagopal, A Vo, A Silvestroni, CE Rubens
Molecular microbiology 56 (5), 1329-1346, 2005
The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf
W Su, S Hopkins, NK Nesser, B Sopher, A Silvestroni, S Ammanuel, ...
The Journal of Immunology 192 (1), 358-366, 2014
Reduction of non-digestible oligosaccharides in soymilk: application of engineered lactic acid bacteria that produce alpha-galactosidase
JG LeBlanc, A Silvestroni, C Connes, V Juillard, GS de Giori, JC Piard, ...
Genet Mol Res 3 (3), 432-440, 2004
A Thermostable α-Galactosidase from Lactobacillus fermentum CRL722: Genetic Characterization and Main Properties
EA Carrera-Silva, A Silvestroni, JG LeBlanc, JC Piard, GS de Giori, ...
Current microbiology 53, 374-378, 2006
Reduction of α‐galactooligosaccharides in soyamilk by Lactobacillus fermentum CRL 722: in vitro and in vivo evaluation of fermented soyamilk
JG LeBlanc, MS Garro, A Silvestroni, C Connes, JC Piard, F Sesma, ...
Journal of applied microbiology 97 (4), 876-881, 2004
Identification of serine/threonine kinase substrates in the human pathogen group B streptococcus
A Silvestroni, KA Jewell, WJ Lin, JE Connelly, MM Ivancic, WA Tao, ...
Journal of proteome research 8 (5), 2563-2574, 2009
Towards probiotic lactic acid bacteria strains to remove raffinose-type sugars present in soy-derived products
C Connes, A Silvestroni, JG Leblanc, V Juillard, GS de Giori, F Sesma, ...
Le Lait 84 (1-2), 207-214, 2004
Evaluation of the genotoxicity of aqueous extracts of Ilex paraguariensis St. Hil.(Aquifoliaceae) using the Allium test
CJ Bidau, AG Amat, M Yajía, DA Martí, AG Riglos, A Silvestroni
Cytologia 69 (2), 109-117, 2004
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
M Sexton, A Silvestroni, T Möller, N Stella
Inflammopharmacology 21, 253-259, 2013
Cytoprotective Effect of Lactobacillus crispatus CTV-05 against Uropathogenic E. coli
DSC Butler, A Silvestroni, AE Stapleton
Pathogens 5 (1), 27, 2016
Genotoxicity evaluation of Allophylus edulis (Camb.) Radlk.(Sapindaceae) aqueous extract
ME Yajia, DA Martí, CJ Bidau, AG Amat, AG Riglos, A Silvestroni
II WOCMAP Congress Medicinal and Aromatic Plants, Part 2: Pharmacognosy …, 1997
Reduction of α-Galactooligosaccharides in Soyamilk by Lactobacillus fermentum CRL 722
JG LeBlanc, MS Garro, A Silvestroni, C Connes, JC Piard, F Sesma, ...
vitro, 2004
Evaluation of cytotoxic and mitodepressive activity of aqueous extracts from thirteen argentine medicinal plants
CJ Bidau, AG Amat, ME Yajia, DA Marti, MD Giménez, AG Riglos, ...
Colegio de Farmacéuticos de la Provincia de Buenos Aires, 2006
126. Robust and Persistent Vaginal Colonization with LACTIN-V Vaginal Lactobacillus crispatus Probiotic in a Double-Blind, Placebo-Controlled (DBPC) Phase 2b Trial to Prevent …
A Stapleton, A Silvestroni, P Roberts, M Cox, H Hayden, M Brittnacher, ...
Open forum infectious diseases 5 (Suppl 1), S8, 2018
A novel unbiased method reveals progressive podocyte globotriaosylceramide accumulation and loss with age in females with Fabry disease
B Najafian, A Silvestroni, A Sokolovskiy, C Tøndel, E Svarstad, B Obrisca, ...
Kidney international 102 (1), 173-182, 2022
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20